RGEN 250516 140.00P(RGEN250516P140000) Stock Price Today

9.55
+2.95+44.70%

15min DelayClose Apr 29 15:59 ET

9.55High7.73Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Teddy123

Mar 4 21:26

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

$908 Devices (MASS.US)$ $Repligen (RGEN.US)$
How Will 908 Devices' $70M Portfolio Sale to Repligen Reshape Its Business Strategy?

Moomoo AI

Feb 29, 2024 01:18

Despite a revenue dip, investors bank on Repligen's future growth, justifying a high P/S ratio. Strong revenue forecasts may keep share prices up, unless analysts' predictions are off.

Repligen Corporation's (NASDAQ:RGEN) Popularity With Investors Is Clear

Moomoo AI

Feb 14, 2024 00:54

No recent insider transactions at Repligen isn't concerning, but last year's transactions aren't encouraging. Modest insider ownership suggests alignment with shareholders. However, Repligen has 1 warning sign that shouldn't be ignored.

Repligen Insiders Sold US$1.7m Of Shares Suggesting Hesitancy

Moomoo AI

Dec 19, 2023 22:38

The growth of Repligen parallels investors' sentiment, with EPS growth and yearly share price increases closely matched. Five-year return of 30% suggests consolidation amidst the firm's continued execution of its growth strategy.

Repligen (NASDAQ:RGEN) Jumps 10.0% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns

Moomoo AI

Nov 1, 2023 22:44

Repligen's projected profit growth and evident undervaluation signal a good investment opportunity. The unreflected potential in the share price suggests now is a desirable time to buy.

Is It Time To Consider Buying Repligen Corporation (NASDAQ:RGEN)?

RGEN250516P140000

News

Comments